Genochem

Become the referent of this startup

Genochem develops small molecules designed for oncology and Central nervous system diseases. Its pipeline includes SF1 inverse agonists, PATCHED inhibitors, STING agonists and spasticity treatment.
Automatic translation

Technologies

  • CHEMTECH

Activity area

  • HEALTHTECH
  • PHARMATECH
  • ONCOLOGY
  • NEUROTECH
  • IMMUNOLOGY

Maturity stage

  • Mature

Contact

http://www.genochem.com

Key information

Year of creation

2012

Workforce

< 10

Maturity stage

Mature

Total fundraising amount

1 200 000 €

Last round table level

Contact information

contact@remove-this.genochem.com

Investment

Total fundraising amount

1 200 000 €

Maximum round table reached

Date Amount Investors Round table
1 200 000,00 €

Similar start-ups